Monoclonal gammopathy of undetermined significance: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Electrophoresis.png|Electrophoresis | |||
</gallery> | |||
Revision as of 00:21, 17 February 2025
Monoclonal gammopathy of undetermined significance (MGUS) is a condition characterized by the presence of an abnormal protein in the blood, known as a monoclonal protein or M protein. This condition is usually discovered during routine blood tests and is often harmless, but it may progress to more serious conditions such as multiple myeloma or other blood disorders.
Symptoms
MGUS itself does not usually cause symptoms. However, if it progresses to a more serious condition, symptoms may include bone pain, fatigue, and weakness.
Causes
The exact cause of MGUS is unknown. It is thought to occur when an error occurs in the production of plasma cells, a type of white blood cell that produces antibodies.
Diagnosis
MGUS is usually discovered during routine blood tests. If an abnormal protein is detected, further tests may be performed to determine the type of protein and the amount present. These tests may include a protein electrophoresis, immunofixation, and free light chain assay.
Treatment
There is no specific treatment for MGUS. Instead, the condition is monitored for any changes that may indicate progression to a more serious condition. This may involve regular blood tests and physical examinations.
Prognosis
The prognosis for MGUS is generally good, as the condition is often harmless. However, a small percentage of people with MGUS may develop a more serious condition, such as multiple myeloma or another blood disorder.


